(42) reported that the mutation frequencies in genes AXIN1, TSC2, SMARCA2, ATRX, and KMT2C were relatively higher, whereas that of CTNNB1 was significantly lower, in Chinese HCC patients with HBV infection cohort than in the HBV-positive HCC subgroup from The Cancer Genome Atlas. This evidence concerns the gene SMARCA2 and hepatocellular carcinoma.